Triple
T6004709
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | onasemnogene abeparvovec |
E133681
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | AAV9-based gene therapy |
C19746
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: AAV9-based gene therapy Context triple: [onasemnogene abeparvovec, instanceOf, AAV9-based gene therapy]
-
A.
Ebola virus disease treatment
Ebola virus disease treatment encompasses the medical interventions, supportive care, and infection control measures used to manage symptoms, reduce mortality, and prevent transmission of the Ebola virus in infected individuals.
-
B.
antisense oligonucleotide
An antisense oligonucleotide is a short, synthetic strand of nucleic acid designed to bind specifically to a target RNA sequence and modulate its function, typically to alter gene expression for therapeutic purposes.
-
C.
pegylated interferon beta-1a
Pegylated interferon beta-1a is a long-acting, pegylated form of interferon used as a disease-modifying therapy to reduce relapses and slow progression in patients with relapsing forms of multiple sclerosis.
-
D.
Ebola vaccine
An Ebola vaccine is a biomedical product designed to stimulate the immune system to provide protection against infection by the Ebola virus.
-
E.
Bruton tyrosine kinase inhibitor
A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
- F. None of above. chosen
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00872444c8190bfaf1739dcec765c |
completed | March 22, 2026, 3:19 p.m. |
Created at: March 22, 2026, 4:06 p.m.